Mar 22, 2022 / 04:00PM GMT
Anne van der Valk - NanoString Technologies, Inc. - Executive
Hello, I'm Anne van der Valk, Senior Regional Marketing Manager in Europe. And I'd like to welcome you to today's webinar, where we are sharing how researchers are using signatures developed from the nCounter PanCancer IO 360 Panel in their own research.
We are first going to start an introduction to the IO 360 Panel with Praveer Sharma, field application scientist at NanoString, where he supports researchers in the San Francisco Bay area. Then we're going to move on to our guest speakers, starting first with Marij Welters from the Leiden University Medical Center in the Netherlands, and she is presenting deciphering the TME in HPV negative and HP positive oropharyngeal squamous cell carcinoma.
Then we'll move on to Lakshmi Chandramohan from NeoGenomics, and she's going to be presenting IO 360 and TIS validation to support the panel's use as a laboratory development test. And then lastly, we have Benjamin Schattling from Universitätsklinikum Hamburg-Eppendorf in Germany, and he's going to close the session with analysis of
NanoString Technologies Inc to Discuss Immuno-Oncology with the nCounter PanCancer IO360 Panel Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot